Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 3 2Phase 1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 1Myasthenia Gravis 1Leukemia 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Pyridostigmine Bromide × Clear all
NCT05919407 2023-06-26

IMPACT-MG

Leiden University Medical Center

Phase 3 Unknown
24 enrolled

Myasthenia Gravis

NCT00075101 2008-08-18

Sleep, Fatigue, and Dexamethosone in Children With Leukemia

National Institute of Nursing Research (NINR)

Phase 3 Completed
134 enrolled
Other hematologic neoplasm

Leukemia, Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡